Halma PLC (LON:HLMA) Rating Reaffirmed
Recently, In recent note issued on Thursday, 17 December, Halma PLC (LON:HLMA) shares have had their Hold Rating reiterated by investment analysts at Investec, who currently has a GBX 840.00 TP on firm. This target by Investec would indicate the possibile downside of -3.95% from the last stock price.
From a total of 10 analysts covering Halma PLC (LON:HLMA) stock, 4 rate it a ”Buy”, 2 a “Sell”, and 4 a ”Hold”. This means that 40% of the ratings are positive. The highest target price is GBX 955 while the lowest target price is GBX 700. The mean of all analyst targets is GBX 809.7 with a -10.45% below today’s (GBX 869) stock price. Halma PLC was the topic of 30 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Numis Securities maintained shares on December 11 with “Add” rating. Barclays Capital maintained shares with “Equal Weight” rating and GBX 715 target share price in a report from a November 18. Jefferies maintained HLMA stock in a recent report from November 25 with “Buy” rating. Investec maintained the rating on November 17. Investec has a “Hold” rating and a GBX 785 price target on shares. Finally, BNP Paribas maintained the stock with “Outperform” rating in a report issued on a November 18.
Approximately 62,602 shares of stock traded hands. Halma plc (LON:HLMA) has risen 11.99% since May 20, 2015 and is uptrending. It has outperformed by 14.26% the S&P500.
Halma plc is a United Kingdom-based company, which is engaged in developing products that secure and protect the elements critical to lives. The company has a market cap of 3.32 billion GBP. The Company’s products save lives, prevent injuries, and protect people and assets around the world. It has 30.83 P/E ratio. The Firm operates in four divisions: Process Safety, which provides products that protect assets and people at work; Infrastructure Safety, which includes products that detect hazards to protect assets and people in public spaces and commercial buildings; Medical, which includes products that improve personal and public health, and Environmental & Analysis, which includes products and technologies for analysis in safety, life sciences and environmental markets.